Tianda Pharmaceuticals Ltd. (0455) Financial Statements

0 Followers

Tianda Pharmaceuticals Ltd. Financial Overview

Tianda Pharmaceuticals Ltd.'s market cap is currently HK$156.95M. The company's EPS TTM is HK$-0.02; its P/E ratio is -2.24; and it has a dividend yield of 1.13%. Tianda Pharmaceuticals Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
	Dec 25	Dec 24	Dec 23	Dec 22	Mar 21
Income Statement
Total Revenue	HK$ 322.94M	HK$ 329.94M	HK$ 532.09M	HK$ 546.69M	HK$ 509.96M
Gross Profit	HK$ 133.31M	HK$ 152.02M	HK$ 255.53M	HK$ 251.52M	HK$ 241.22M
Operating Income	HK$ -54.09M	HK$ -54.15M	HK$ -29.02M	HK$ -70.14M	HK$ -42.03M
EBITDA	HK$ -15.44M	HK$ -15.92M	HK$ 15.66M	HK$ -19.89M	HK$ -5.14M
Net Income	HK$ -70.00M	HK$ -61.37M	HK$ -24.16M	HK$ -54.64M	HK$ -19.77M
Balance Sheet
Cash & Short-Term Investments	HK$ 64.81M	HK$ 85.69M	HK$ 162.44M	HK$ 343.44M	HK$ 348.58M
Total Assets	HK$ 747.83M	HK$ 765.02M	HK$ 917.29M	HK$ 1.09B	HK$ 1.16B
Total Debt	HK$ 132.66M	HK$ 127.44M	HK$ 113.60M	HK$ 141.05M	HK$ 160.43M
Net Debt	HK$ 67.85M	HK$ 41.76M	HK$ -48.84M	HK$ -199.23M	HK$ -173.57M
Total Liabilities	HK$ 291.46M	HK$ 259.36M	HK$ 325.35M	HK$ 434.23M	HK$ 375.08M
Stockholders' Equity	HK$ 456.64M	HK$ 505.84M	HK$ 592.07M	HK$ 627.83M	HK$ 756.75M
Cash Flow
Free Cash Flow	HK$ 2.80M	HK$ -52.30M	HK$ -116.04M	HK$ 54.73M	HK$ -61.98M
Operating Cash Flow	HK$ 14.42M	HK$ -9.70M	HK$ -49.76M	HK$ 79.11M	HK$ -8.23M
Investing Cash Flow	HK$ -20.38M	HK$ -31.77M	HK$ -69.10M	HK$ -12.20M	HK$ 86.35M
Financing Cash Flow	HK$ -15.31M	HK$ -30.65M	HK$ -57.39M	HK$ -28.98M	HK$ -1.29M

Currency in HKD

Tianda Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Tianda Pharmaceuticals Ltd. Liabilities to Assets

Balance Sheet >

Tianda Pharmaceuticals Ltd. Cash Flow

Cash Flow >

Tianda Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Tianda Pharmaceuticals Ltd. financials statements